Endexx Corporation (EDXC) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Endexx Corporation (EDXC) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 36/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Endexx Corporation (EDXC) Gesundheitswesen & Pipeline-Uebersicht
Endexx Corporation focuses on the cannabidiol (CBD) health and wellness market, offering a range of CBD-based products for humans and pets. Operating in the specialty and generic drug manufacturing sector, the company leverages its e-commerce platform and retail partnerships to distribute CBD creams, oils, and other health and beauty products.
Investmentthese
Endexx Corporation presents a speculative investment opportunity within the burgeoning CBD market. With a negative P/E ratio of -0.00 and a high profit margin of 1181.3%, the company's financial metrics suggest potential volatility. Key value drivers include expanding its product line and increasing its distribution network. Growth catalysts involve capitalizing on the increasing acceptance and legalization of CBD products. Potential risks include intense competition, regulatory uncertainties, and the challenges of operating on the OTC market. Investors should carefully consider these factors when evaluating EDXC.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap: $0.00B indicates the company is a microcap stock.
- P/E Ratio: -0.00 reflecting that the company is currently not profitable.
- Profit Margin: 1181.3% suggests potential profitability if revenue increases.
- Gross Margin: -96.0% indicates significant cost of goods sold relative to revenue.
- Beta: -0.81 suggests the stock is less volatile than the market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Diverse product range including creams, oils, capsules, and pet products.
- Established e-commerce platform (cbdunlimited.com).
- Focus on the growing CBD health and wellness market.
- Hemp-derived health and beauty care products.
Schwaechen
- Small company size with only 10 employees.
- Negative gross margin (-96.0%).
- Limited brand recognition compared to larger competitors.
- Reliance on a single e-commerce platform and limited retail partnerships.
Katalysatoren
- Upcoming: Potential changes in CBD regulations at the state or federal level could significantly impact the company's market access and growth prospects.
- Ongoing: Increasing consumer awareness and acceptance of CBD products may drive higher demand and sales for Endexx's product line.
- Ongoing: Expansion of the company's distribution network through strategic partnerships with retailers and healthcare providers.
- Upcoming: Launch of new CBD-infused products targeting specific health and wellness needs.
- Ongoing: Optimization of the company's e-commerce platform to improve user experience and drive online sales.
Risiken
- Potential: Intense competition from larger CBD companies with greater resources and brand recognition.
- Potential: Evolving and uncertain regulatory landscape could restrict the sale or marketing of CBD products.
- Potential: Negative publicity or health concerns related to CBD products could damage the company's reputation and sales.
- Ongoing: Limited financial resources and small company size may hinder the company's ability to compete effectively.
- Ongoing: Reliance on a single e-commerce platform and limited retail partnerships increases the company's vulnerability to market changes.
Wachstumschancen
- Expansion of Product Line: Endexx can grow by introducing new CBD-infused products targeting specific health and wellness needs. The market for specialized CBD products, such as those targeting sleep, anxiety, and pain management, is expanding rapidly. By investing in research and development to create innovative formulations, Endexx can attract new customers and increase revenue streams. This expansion could tap into a market projected to reach $20 billion by 2028.
- Strategic Partnerships: Forming partnerships with established retailers and healthcare providers can significantly expand Endexx's distribution network. Collaborating with pharmacies, wellness centers, and online marketplaces can provide access to a broader customer base. These partnerships can also enhance the company's credibility and brand recognition. The timeline for establishing such partnerships is ongoing, with potential benefits realized within the next 1-2 years.
- Geographic Expansion: Expanding into new geographic markets, both domestically and internationally, represents a significant growth opportunity. As CBD regulations evolve globally, Endexx can target regions with favorable regulatory environments and high consumer demand. This expansion requires careful market research and strategic planning to ensure successful market entry. The global CBD market is expected to grow substantially over the next five years, presenting a lucrative opportunity for Endexx.
- E-commerce Optimization: Enhancing the user experience and functionality of cbdunlimited.com can drive increased online sales. Improving website navigation, offering personalized product recommendations, and implementing targeted marketing campaigns can attract and retain customers. Investing in e-commerce optimization can lead to higher conversion rates and increased revenue. This is an ongoing process that can yield immediate and long-term benefits.
- Pet Product Innovation: Capitalizing on the growing market for CBD pet products can drive significant revenue growth. Developing new formulations and delivery methods specifically tailored to pets can attract pet owners seeking natural health solutions for their animals. This includes CBD-infused treats, oils, and topicals designed to address various pet health concerns. The pet CBD market is projected to reach $1 billion by 2027, offering a substantial opportunity for Endexx.
Chancen
- Expansion into new geographic markets.
- Development of new CBD-infused products.
- Strategic partnerships with retailers and healthcare providers.
- Capitalizing on the growing market for CBD pet products.
Risiken
- Intense competition from larger CBD companies.
- Evolving and uncertain regulatory landscape.
- Changing consumer preferences and market trends.
- Potential negative publicity or health concerns related to CBD products.
Wettbewerbsvorteile
- Established e-commerce platform (cbdunlimited.com).
- Diverse range of CBD products for humans and pets.
- Focus on hemp-derived health and beauty care products.
- Distribution network through online and in-store retailers.
Ueber EDXC
Endexx Corporation, formerly known as CBD Unlimited, Inc., was rebranded in May 2020 and is dedicated to the manufacturing and sale of cannabidiol (CBD)-based products. Headquartered in Cave Creek, Arizona, the company targets the health and wellness market, providing a diverse range of products including CBD creams, oils, capsules, extracts, topicals, drinks, and chocolates. Endexx also caters to the pet market with specialized CBD products. The company distributes its products through its e-commerce platform, cbdunlimited.com, as well as through various online and in-store retailers. Endexx focuses on hemp-derived health and beauty care products designed to provide therapeutic relief from pain and inflammation for both humans and pets. The company aims to capitalize on the growing demand for CBD products in the health and wellness sector by offering a wide array of accessible and consumer-friendly options.
Was das Unternehmen tut
- Manufactures CBD-based creams for pain relief.
- Produces CBD oils for general wellness.
- Creates CBD capsules for easy consumption.
- Offers CBD extracts for concentrated doses.
- Develops CBD topicals for localized application.
- Sells CBD-infused drinks and chocolates.
- Provides CBD products specifically for pets.
- Distributes hemp-derived health and beauty care products.
Geschaeftsmodell
- Manufacturing and selling CBD-based products.
- Distribution through e-commerce platform cbdunlimited.com.
- Partnerships with online and in-store retailers.
- Focus on therapeutic relief of pain and inflammation for humans and pets.
Branchenkontext
Endexx Corporation operates within the rapidly expanding CBD health and wellness market. This market is characterized by increasing consumer demand for natural health solutions and a growing acceptance of CBD products. The competitive landscape includes numerous players, ranging from large pharmaceutical companies to smaller, specialized CBD manufacturers. Endexx aims to differentiate itself through its diverse product range and multi-channel distribution strategy. The industry faces ongoing regulatory challenges and evolving consumer preferences.
Wichtige Kunden
- Individuals seeking natural health and wellness solutions.
- Pet owners looking for CBD products for their pets.
- Retailers offering CBD products to their customers.
- Consumers interested in alternative pain relief methods.
Finanzdaten
Chart & Info
Endexx Corporation (EDXC) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer EDXC verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer EDXC.
Kursziele
Wall-Street-Kurszielanalyse fuer EDXC.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von EDXC auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Todd A. Davis
CEO
Todd A. Davis serves as the CEO of Endexx Corporation, managing a team of 10 employees. His background includes experience in the health and wellness sector, with a focus on developing and marketing innovative products. He has a track record of leading small teams and driving growth through strategic partnerships and product development. Davis is committed to expanding Endexx's presence in the CBD market and delivering high-quality products to consumers.
Erfolgsbilanz: Under Todd A. Davis's leadership, Endexx Corporation has focused on expanding its product line and distribution network. Key achievements include the rebranding of the company in May 2020 and the ongoing development of new CBD-infused products. Davis has also focused on strengthening the company's e-commerce platform and building relationships with key retailers.
EDXC OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Endexx Corporation may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and greater volatility.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the risk of investing in EDXC.
- Low trading volume and wide bid-ask spreads can lead to price volatility.
- OTC Other tier companies are subject to less regulatory oversight.
- Potential for fraud or manipulation is higher on the OTC market.
- Liquidity risk may make it difficult to exit the investment.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company has an operational e-commerce website (cbdunlimited.com).
- Company manufactures and sells CBD-based products.
- Company has been in operation since at least 2020 (rebranded from CBD Unlimited, Inc.).
- Company has a CEO and management team.
- Company is headquartered in the United States.
Haeufige Fragen zu EDXC
What are the key factors to evaluate for EDXC?
Endexx Corporation (EDXC) currently holds an AI score of 36/100, indicating low score. Key strength: Diverse product range including creams, oils, capsules, and pet products.. Primary risk to monitor: Potential: Intense competition from larger CBD companies with greater resources and brand recognition.. This is not financial advice.
How frequently does EDXC data refresh on this page?
EDXC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EDXC's recent stock price performance?
Recent price movement in Endexx Corporation (EDXC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product range including creams, oils, capsules, and pet products.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EDXC overvalued or undervalued right now?
Determining whether Endexx Corporation (EDXC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EDXC?
Before investing in Endexx Corporation (EDXC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EDXC to a portfolio?
Potential reasons to consider Endexx Corporation (EDXC) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product range including creams, oils, capsules, and pet products.. Additionally: Established e-commerce platform (cbdunlimited.com).. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of EDXC?
Yes, most major brokerages offer fractional shares of Endexx Corporation (EDXC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EDXC's earnings and financial reports?
Endexx Corporation (EDXC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for EDXC earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available on OTC-listed companies.
- Financial data may be outdated or incomplete.
- AI analysis pending for EDXC.